Oragenics (OGEN) Amortizatization of Intangibles (2012)
Oragenics' (OGEN) quarterly Amortizatization of Intangibles came in at $443970.0 in Q3 2012, up 1281.96% on a QoQ basis from $32126.0 in Q2 2012.
Oragenics (OGEN) Amortizatization of Intangibles (2012) Analysis & Trends
Oragenics (OGEN) has 1 years of Amortizatization of Intangibles data on file, last reported at $443970.0 in Q3 2012.
- Quarterly Amortizatization of Intangibles changed N/A year-over-year to $443970.0 in Q3 2012, while the trailing twelve-month figure through Dec 2012 was $483559.0 (changed N/A YoY) and the FY2012 annual result came in at $483559.0, changed N/A from the prior year.
- Amortizatization of Intangibles rose to $443970.0 in Q3 2012, from $32126.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $443970.0 in Q3 2012 to a low of $7463.0 in Q1 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Oragenics | 2.31 Mn | 2.31 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2012 | 443,970.00 |
| Sep 30, 2012 | 443,970.00 |
| Jun 30, 2012 | 32,126.00 |
| Jun 30, 2012 | 32,126.00 |
| Mar 31, 2012 | 7,463.00 |
| Mar 31, 2012 | 7,463.00 |